FDA Inspection
BSO LLCBSO LLC – FDA Inspection, Jul 16, 2025
Record Details
This FDA Inspection record concerns BSO LLC, with an inspection on July 16, 2025, issued by the Denver District Office, covering human drugs.
View Company Profile
ID · ba03a20e-19ea-4f9e-a133-e92c3a2106a7
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1275884
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
9- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.166(a)(3)Valid stability test methods
- 21 CFR 211.166(a)(4)Testing in same container - closure system
- 21 CFR 211.170(b)Annual visual exams of drug products
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.42(c)(10)(i)Floors, walls, ceiling surfaces
- 21 CFR 211.63Equipment Design, Size and Location
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BSO LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 3, 2024 | OAI | Drug Quality Assurance | |
| March 11, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 2, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BSO LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.